# US 2005/0089864 A1 · Signalling aptamer complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0089864 A1
- Document ID: US20050089864A1
- Status: Published application
- Kind: A1
- Application number: 10/502,190
- Filed: 2003-01-22
- Published: 2005-04-28
- Earliest claimed: 2002-01-22
- Inventors: Yingfu Li; Razan Nutiu
- Web page: https://patentgrep.com/patent/US20050089864A1

## CPC

- C12N 15/115: Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C07K 2319/00: Fusion polypeptide
- C12N 2310/3517: Marker; Tag
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Aptamer based fluorescent reporters that function based on a switch from DNA/DNA duplex conformation to DNA/target conformation are provided. The DNA/DNA duplex is formed between the aptamer DNA sequence and an oligonucleotide carrying a reporter moiety. When the aptamer target is present, the aptamer assumes a tertiary structure for binding to the target. The formation of the tertiary structure forces the dissociation of the duplex structure and a signal is generated. The signal is preferably a fluorescent signal due to spatial separation of a fluorophore/quencher pair.

## Claims

### Claim 1

A signalling aptamer complex for the detection of a target, the aptamer complex comprising:
i) a first oligonucleotide having a target binding domain, and
ii) at least one additional oligonucleotide having a sequence complementary to a region of said first oligonucleotide, wherein in the absence of the target, complementary regions of said first oligonucleotide and said additional oligonucleotide form a duplex structure and wherein in the presence of the target, said duplex structure dissociates and a reporter signal is generated.

### Claim 2 (depends on 1)

The signalling aptamer of claim 1 wherein a reporter moiety is associated with the additional oligonucleotide and is selected from the group consisting of a fluorophore, a quencher, a radioactive marker, an enzyme and a density particle.

### Claim 3 (depends on 1)

The signalling aptamer complex according to claim 1, wherein said first oligonucleotide is labeled with a fluorophore and said additional oligonucleotide has a quencher moiety associated therewith.

### Claim 4 (depends on 1)

The signalling aptamer complex of claim 1, wherein said first oligonucleotide has a quencher moiety and said additional oligonucleotide is labeled with a fluorophore.

### Claim 5 (depends on 1)

The signaling aptamer complex of claim 1, wherein said first oligonucleotide comprises an FDNA binding domain capable of forming a duplex with a fluorophore modified oligonucleotide (FDNA).

### Claim 6 (depends on 1)

The signalling aptamer complex of claim 1, wherein said first oligonucleotide comprises 3-10 nucleotides inserted adjacent to the target binding domain wherein said nucleotides participate in the duplex formed between said first oligonucleotide and said additional oligonucleotide.

### Claim 7 (depends on 1)

The signalling aptamer complex of claim 1, wherein the first oligonucleotide comprises an ATP-binding domain or a thrombin-binding domain.

### Claim 8

A signalling aptamer complex for detection of a target, said aptamer complex comprising:
i) a first oligonucleotide having a target binding domain and a tagging domain,
ii) a second oligonucleotide labeled with a fluorophore and having a sequence complementary to said tagging domain, and
iii) a third oligonucleotide modified with a quencher and having a sequence complementary to a region of said target binding domain, wherein in the absence of a target, a first duplex is formed between said second oligonucleotide and said tagging domain and a second duplex is formed between said third oligonucleotide and a segment of said target binding domain whereby said quencher and said fluorophore are sufficiently close to one another to quench a fluorescent signal.

### Claim 9

A signalling aptamer complex for detection of a target, said aptamer complex comprising:
i) a first oligonucleotide having a target binding domain and a tagging domain,
ii) a second oligonucleotide modified with a quencher and having a sequence complementary to said tagging domain, and
iii) a third oligonucleotide labeled with a fluorophore and having a sequence complementary to a region of said target binding domain, wherein in the absence of a target, a first duplex is formed between said second oligonucleotide and said tagging domain and a second duplex is formed between said third oligonucleotide and a segment of said target binding domain whereby said quencher and said fluorophore are sufficiently close to one another to quench a fluorescent signal.

### Claim 10 (depends on 8)

A signalling aptamer complex according to claim 8, wherein said first oligonucleotide includes additional nucleotides intermediate said target binding domain and said tagging domain and said third oligonucleotide is complementary to and forms said second duplex with said additional nucleotides and the adjacent portion of the target binding domain.

### Claim 11 (depends on 10)

A signalling aptamer complex according to claim 10 wherein, in the presence of a target, said first oligonucleotide assumes a tertiary structure and said third oligonucleotide dissociates from said first oligonucleotide and a fluorescent signal is detectable.

### Claim 12

A signalling aptamer complex comprising:
i) a first oligonucleotide having a target binding domain
ii) a second fluorphore-labeled oligonucleotide hybridized to a first segment of the target binding domain, and
iii) a third quencher-modified oligonucleotide hybridized to a second segment of said target binding domain adjacent to the first segment.

### Claim 13 (depends on 12)

A signalling aptamer complex according to claim 12, wherein said flurophore labeled oligonucleotide comprises two fluorophores capable of exhibiting fluorescence energy transfer.

### Claim 14

A method for modifying an aptamer into a signalling aptamer, said method comprising interacting a reporter oligonucleotide, having a nucleotide sequence complementary to a target binding segment of the aptamer, with the aptamer to form a duplex structure.

### Claim 15 (depends on 14)

The method of claim 14 wherein said aptamer is labeled with a fluorophore and said reporter oligonucleotide is modified with a quencher.

### Claim 16 (depends on 14)

The method of claim 14 comprising modifying said aptamer to include a tagging domain at one end, forming a duplex between said tagging domain and a complementary fluorophore labeled-oligonucleotide, wherein said reporter oligonucleotide is modified with a quencher.

### Claim 17 (depends on 1)

A method for detecting the presence of a target, said method comprising:
i) providing a signalling aptamer complex, as defined in claim 1;
ii) interacting said complex with a target solution; and
iii) measuring a signal.

### Claim 18

A modified aptamer comprising a target binding domain and an oligonucleotide binding domain fused at one end.

### Claim 19 (depends on 18)

A modified aptamer according to claim 18 wherein the oligonucleotide binding domain hybridizes to a flurophore-modified oligonucleotide.

### Claim 20

A kit for the conversion of an aptamer to a signalling aptamer complex, said kit comprising a fluorophore labeled FDNA and a quencher modified QDNA.

### Claim 21 (depends on 9)

A signalling aptamer complex according to claim 9, wherein said first oligonucleotide includes additional nucleotides intermediate said target binding domain and said tagging domain and said third oligonucleotide is complementary to and forms said second duplex with said additional nucleotides and the adjacent portion of the target binding domain.

### Claim 22 (depends on 21)

A signalling aptamer complex according to claim 21 wherein, in the presence of a target, said first oligonucleotide assumes a tertiary structure and said third oligonucleotide dissociates from said first oligonucleotide and a fluorescent signal is detectable.

### Claim 23 (depends on 8)

A method for detecting the presence of a target, said method comprising:
i) providing a signalling aptamer complex, as defined in claim 8;
ii) interacting said complex with a target solution; and
iii) measuring a signal.
